JEREMY DEUTSCH MD NPI 1528263043

NPI Details

Jeremy Deutsch, MD is a hematology and oncology internal medicine in Wichita, KS with 19 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jeremy Deutsch, MD NPI is 1528263043. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:2007

The provider's business location address is:

818 N EMPORIA ST
SUITE 403
WICHITA, KS
ZIP 67214-729
Phone: (316) 262-4467
Fax: (316) 262-0706

The NPI 1528263043 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, lanreotide, 1 mg (HCPCS:J1930)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, daratumumab, 10 mg (HCPCS:J9145)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Magnesium level (HCPCS:83735)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Phosphate level (HCPCS:84100)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Ct scan of chest with contrast (HCPCS:71260)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Unclassified drugs (HCPCS:J3490)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (HCPCS:Q9965)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of chest without contrast (HCPCS:71250)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Total protein level, urine (HCPCS:84156)
• Folic acid level, serum (HCPCS:82746)
• Red blood count, automated test (HCPCS:85045)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Uric acid level, blood (HCPCS:84550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Vitamin d-3 level (HCPCS:82306)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Blood creatinine level (HCPCS:82565)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)

The enumeration date for this NPI number is 6/15/2007 and was last updated on 9/25/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.